Lazard Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1K | Sell |
|
|||||
|
2024
Q4 | $47K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $0 | Sell |
|
|||||
|
2024
Q1 | $15K | Sell |
|
|||||
|
2023
Q4 | $19K | Buy |
|
|||||
|
2023
Q3 | $20K | Sell |
|
|||||
|
2023
Q2 | $104K | Buy |
|
|||||
|
2023
Q1 | $21K | Sell |
|
|||||
|
2022
Q4 | $75K | Sell |
|
|||||
|
2022
Q3 | $131K | Buy |
|
|||||
|
2022
Q2 | $111K | Buy |
|
|||||
|
2022
Q1 | $70K | Buy |
|
|||||
|
2021
Q4 | $65K | Buy |
|
|||||
|
2021
Q3 | $65K | Sell |
|
|||||
|
2021
Q2 | $193K | Buy |
|
|||||
|
2021
Q1 | $2K | Sell |
|
|||||
|
2020
Q4 | $83K | Buy |
|